Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed. Methods for altering the biological activity of the peptides are disclosed.

 
Web www.patentalert.com

< Sh2 domain binding inhibitors

< Patient management network

> Patient management network

> Tetralin and indane derivatives and uses thereof
~ 00278